Company Badge
USPTO Data Jan 1 1976 - Oct 13 2026
8 Patents
#132 in Cincinnati, OH
#1,440 in Ohio
#35,924 in US
Aerpio Pharmaceuticals, Inc.
Forward Citations = 52
10 inventors:
Cincinnati, OH, United States of America
Aerpio Pharmaceuticals, Inc.
% Expired Patents = 12.5
CIPO Patents = 5
EPO Patents = 1
Forward Citations = 52
Loading Chart...
Loading Chart...
10 inventors (with patents filed for the assignee):
Kevin Gene Peters (7 out of 35 patents)
Michael Allen Flynn (3 out of 6 patents)
James Copp (1 out of 1 patent)
4. Jeffrey Lyle Gray (1 out of 23 patents)
5. Cynthia Monesa Clark (1 out of 16 patents)
6. Ryan Matthew Nichols (1 out of 16 patents)
7. Matthew B Maier (1 out of 16 patents)
8. Kande K D Amarasinghe (1 out of 16 patents)
9. Robert A Shalwitz (1 out of 33 patents)
10. John M Janusz (1 out of 37 patents)
11. Mathew Brian Maier (0 patent)
12. Ryan Nichols (0 patent)
13. Kande Amarasinghe (0 patent)
14. Matthew Brian Maier (0 patent)
8 patents:
Company Overview
Aerpio Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing novel treatments for ocular diseases, specifically targeting the bioactive lipid mediator sphingosine-1-phosphate (S1P) pathway. Their lead product candidate, razuprotafib, is currently in clinical development for diabetic retinopathy, where abnormal S1P signaling plays a key role in the underlying pathology. Aerpio is dedicated to advancing innovative therapies to improve outcomes for patients with sight-threatening conditions.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Aerpio Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/aerpio-pharmaceuticals
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
5 patents (CIPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
1 patent (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]